The 2025 Annual Report of the Advisory Group on Biomarkers of Effect (AGoB) details the group’s establishment, objectives, and activities in supporting EFSA’s development of guidance on biomarkers of effect (BoEs) in regulatory risk assessment. The report outlines AGoB’s collaborative efforts, meeting summaries, scientific advice and plans for future work.
2025 Annual Report of the Advisory Group on Biomarkers of Effect
Dimosthenis Sarigiannis
;
2026-01-01
Abstract
The 2025 Annual Report of the Advisory Group on Biomarkers of Effect (AGoB) details the group’s establishment, objectives, and activities in supporting EFSA’s development of guidance on biomarkers of effect (BoEs) in regulatory risk assessment. The report outlines AGoB’s collaborative efforts, meeting summaries, scientific advice and plans for future work.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
